| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 4.07e-09 | 16 | 26 | 4 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.33e-08 | 21 | 26 | 4 | GO:0030228 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.60e-08 | 749 | 26 | 10 | GO:0005509 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 2.20e-06 | 20 | 26 | 3 | GO:0034185 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 3.00e-06 | 323 | 26 | 6 | GO:1901681 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.93e-06 | 188 | 26 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 4.26e-06 | 85 | 26 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | heparin binding | 4.36e-06 | 192 | 26 | 5 | GO:0008201 | |
| GeneOntologyMolecularFunction | fibronectin binding | 1.60e-05 | 38 | 26 | 3 | GO:0001968 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 2.19e-05 | 268 | 26 | 5 | GO:0005539 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 3.92e-05 | 51 | 26 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | collagen binding | 1.56e-04 | 81 | 26 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | hormone binding | 3.18e-04 | 103 | 26 | 3 | GO:0042562 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 6.48e-04 | 29 | 26 | 2 | GO:0043395 | |
| GeneOntologyMolecularFunction | structural molecule activity | 8.29e-04 | 891 | 26 | 6 | GO:0005198 | |
| GeneOntologyMolecularFunction | laminin binding | 8.91e-04 | 34 | 26 | 2 | GO:0043236 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 9.45e-04 | 35 | 26 | 2 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 9.45e-04 | 35 | 26 | 2 | GO:0071814 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 1.17e-03 | 39 | 26 | 2 | GO:0070325 | |
| GeneOntologyMolecularFunction | integrin binding | 1.48e-03 | 175 | 26 | 3 | GO:0005178 | |
| GeneOntologyMolecularFunction | protease binding | 1.63e-03 | 181 | 26 | 3 | GO:0002020 | |
| GeneOntologyMolecularFunction | ribonucleoprotein complex binding | 2.36e-03 | 206 | 26 | 3 | GO:0043021 | |
| GeneOntologyMolecularFunction | coreceptor activity | 3.94e-03 | 72 | 26 | 2 | GO:0015026 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 4.05e-03 | 73 | 26 | 2 | GO:0050840 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 9.12e-03 | 111 | 26 | 2 | GO:0003727 | |
| GeneOntologyBiologicalProcess | growth plate cartilage development | 5.63e-06 | 29 | 25 | 3 | GO:0003417 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | 6.01e-06 | 1189 | 25 | 9 | GO:0044087 | |
| GeneOntologyBiologicalProcess | endochondral bone growth | 1.40e-05 | 39 | 25 | 3 | GO:0003416 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 1.41e-05 | 5 | 25 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 1.41e-05 | 5 | 25 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 1.51e-05 | 40 | 25 | 3 | GO:0097242 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | 1.85e-05 | 1366 | 25 | 9 | GO:0051130 | |
| GeneOntologyBiologicalProcess | bone growth | 2.16e-05 | 45 | 25 | 3 | GO:0098868 | |
| GeneOntologyBiologicalProcess | cartilage development involved in endochondral bone morphogenesis | 2.46e-05 | 47 | 25 | 3 | GO:0060351 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 2.95e-05 | 7 | 25 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 3.03e-05 | 309 | 25 | 5 | GO:1901888 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 3.93e-05 | 8 | 25 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 9.24e-05 | 12 | 25 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 1.17e-04 | 79 | 25 | 3 | GO:0060350 | |
| GeneOntologyBiologicalProcess | cellular response to heat | 1.26e-04 | 81 | 25 | 3 | GO:0034605 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 1.27e-04 | 14 | 25 | 2 | GO:1904350 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 1.84e-04 | 92 | 25 | 3 | GO:0048844 | |
| GeneOntologyBiologicalProcess | negative regulation of focal adhesion assembly | 1.90e-04 | 17 | 25 | 2 | GO:0051895 | |
| GeneOntologyBiologicalProcess | regulation of RNA export from nucleus | 1.90e-04 | 17 | 25 | 2 | GO:0046831 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-substrate junction organization | 1.90e-04 | 17 | 25 | 2 | GO:0150118 | |
| GeneOntologyBiologicalProcess | regulation of nucleobase-containing compound transport | 2.64e-04 | 20 | 25 | 2 | GO:0032239 | |
| GeneOntologyBiologicalProcess | endocytosis | 3.75e-04 | 827 | 25 | 6 | GO:0006897 | |
| GeneOntologyBiologicalProcess | lysosomal protein catabolic process | 3.83e-04 | 24 | 25 | 2 | GO:1905146 | |
| GeneOntologyBiologicalProcess | transcytosis | 3.83e-04 | 24 | 25 | 2 | GO:0045056 | |
| GeneOntologyBiologicalProcess | response to heat | 4.12e-04 | 121 | 25 | 3 | GO:0009408 | |
| GeneOntologyBiologicalProcess | bone morphogenesis | 4.43e-04 | 124 | 25 | 3 | GO:0060349 | |
| GeneOntologyBiologicalProcess | ossification | 4.99e-04 | 562 | 25 | 5 | GO:0001503 | |
| GeneOntologyBiologicalProcess | growth | 5.02e-04 | 1235 | 25 | 7 | GO:0040007 | |
| GeneOntologyBiologicalProcess | lipoprotein transport | 5.23e-04 | 28 | 25 | 2 | GO:0042953 | |
| GeneOntologyBiologicalProcess | protein catabolic process in the vacuole | 5.23e-04 | 28 | 25 | 2 | GO:0007039 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 5.28e-04 | 569 | 25 | 5 | GO:0034329 | |
| GeneOntologyBiologicalProcess | artery development | 5.43e-04 | 133 | 25 | 3 | GO:0060840 | |
| GeneOntologyBiologicalProcess | lipoprotein localization | 5.61e-04 | 29 | 25 | 2 | GO:0044872 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | 5.85e-04 | 582 | 25 | 5 | GO:0044089 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 6.75e-04 | 337 | 25 | 4 | GO:0006898 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 6.84e-04 | 32 | 25 | 2 | GO:0048266 | |
| GeneOntologyBiologicalProcess | connective tissue development | 7.21e-04 | 343 | 25 | 4 | GO:0061448 | |
| GeneOntologyBiologicalProcess | regulation of ossification | 7.27e-04 | 147 | 25 | 3 | GO:0030278 | |
| GeneOntologyBiologicalProcess | response to unfolded protein | 7.42e-04 | 148 | 25 | 3 | GO:0006986 | |
| GeneOntologyBiologicalProcess | activation of adenylate cyclase activity | 7.73e-04 | 34 | 25 | 2 | GO:0007190 | |
| GeneOntologyBiologicalProcess | response to topologically incorrect protein | 1.03e-03 | 166 | 25 | 3 | GO:0035966 | |
| GeneOntologyBiologicalProcess | positive regulation of adenylate cyclase activity | 1.07e-03 | 40 | 25 | 2 | GO:0045762 | |
| GeneOntologyBiologicalProcess | negative regulation of cell junction assembly | 1.12e-03 | 41 | 25 | 2 | GO:1901889 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-matrix adhesion | 1.24e-03 | 43 | 25 | 2 | GO:0001953 | |
| GeneOntologyBiologicalProcess | response to hormone | 1.27e-03 | 1042 | 25 | 6 | GO:0009725 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | 1.35e-03 | 1458 | 25 | 7 | GO:0051247 | |
| GeneOntologyBiologicalProcess | import into cell | 1.48e-03 | 1074 | 25 | 6 | GO:0098657 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclase activity | 1.54e-03 | 48 | 25 | 2 | GO:0031281 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 1.54e-03 | 48 | 25 | 2 | GO:0043277 | |
| GeneOntologyBiologicalProcess | positive regulation of lyase activity | 1.60e-03 | 49 | 25 | 2 | GO:0051349 | |
| GeneOntologyBiologicalProcess | response to pain | 1.73e-03 | 51 | 25 | 2 | GO:0048265 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 1.82e-03 | 202 | 25 | 3 | GO:0051963 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.89e-03 | 445 | 25 | 4 | GO:0141091 | |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | 1.95e-03 | 1133 | 25 | 6 | GO:0001932 | |
| GeneOntologyBiologicalProcess | response to temperature stimulus | 1.97e-03 | 208 | 25 | 3 | GO:0009266 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 1.32e-04 | 80 | 26 | 3 | GO:0005905 | |
| GeneOntologyCellularComponent | cell surface | 3.17e-04 | 1111 | 26 | 7 | GO:0009986 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 4.35e-04 | 530 | 26 | 5 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.14e-03 | 656 | 26 | 5 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.16e-03 | 658 | 26 | 5 | GO:0030312 | |
| GeneOntologyCellularComponent | axonal growth cone | 1.43e-03 | 45 | 26 | 2 | GO:0044295 | |
| Domain | LDLR_class-A_CS | 7.17e-19 | 40 | 25 | 9 | IPR023415 | |
| Domain | Ldl_recept_a | 2.31e-18 | 45 | 25 | 9 | PF00057 | |
| Domain | - | 2.88e-18 | 46 | 25 | 9 | 4.10.400.10 | |
| Domain | LDLRA_1 | 4.37e-18 | 48 | 25 | 9 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 5.35e-18 | 49 | 25 | 9 | IPR002172 | |
| Domain | LDLa | 5.35e-18 | 49 | 25 | 9 | SM00192 | |
| Domain | LDLRA_2 | 5.35e-18 | 49 | 25 | 9 | PS50068 | |
| Domain | EGF_CA | 7.71e-18 | 86 | 25 | 10 | PF07645 | |
| Domain | EGF_CA | 2.92e-16 | 122 | 25 | 10 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.46e-16 | 124 | 25 | 10 | IPR001881 | |
| Domain | TSP3 | 2.81e-15 | 5 | 25 | 5 | PS51234 | |
| Domain | TSP_CTER | 2.81e-15 | 5 | 25 | 5 | PS51236 | |
| Domain | - | 2.81e-15 | 5 | 25 | 5 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 2.81e-15 | 5 | 25 | 5 | IPR008859 | |
| Domain | TSP_C | 2.81e-15 | 5 | 25 | 5 | PF05735 | |
| Domain | Thrombospondin_3_rpt | 2.81e-15 | 5 | 25 | 5 | IPR017897 | |
| Domain | TSP_3 | 2.81e-15 | 5 | 25 | 5 | PF02412 | |
| Domain | Thrombospondin_3-like_rpt | 2.81e-15 | 5 | 25 | 5 | IPR003367 | |
| Domain | TSP_type-3_rpt | 2.81e-15 | 5 | 25 | 5 | IPR028974 | |
| Domain | EGF_3 | 3.78e-15 | 235 | 25 | 11 | PS50026 | |
| Domain | EGF-like_dom | 7.17e-15 | 249 | 25 | 11 | IPR000742 | |
| Domain | EGF_1 | 9.33e-15 | 255 | 25 | 11 | PS00022 | |
| Domain | EGF-like_CS | 1.21e-14 | 261 | 25 | 11 | IPR013032 | |
| Domain | EGF_2 | 1.43e-14 | 265 | 25 | 11 | PS01186 | |
| Domain | EGF | 2.27e-13 | 235 | 25 | 10 | SM00181 | |
| Domain | Growth_fac_rcpt_ | 2.86e-13 | 156 | 25 | 9 | IPR009030 | |
| Domain | EGF_Ca-bd_CS | 3.97e-13 | 97 | 25 | 8 | IPR018097 | |
| Domain | EGF_CA | 4.69e-13 | 99 | 25 | 8 | PS01187 | |
| Domain | Ldl_recept_b | 5.57e-12 | 14 | 25 | 5 | PF00058 | |
| Domain | LDLRB | 5.57e-12 | 14 | 25 | 5 | PS51120 | |
| Domain | LY | 8.35e-12 | 15 | 25 | 5 | SM00135 | |
| Domain | LDLR_classB_rpt | 8.35e-12 | 15 | 25 | 5 | IPR000033 | |
| Domain | EGF | 2.34e-10 | 126 | 25 | 7 | PF00008 | |
| Domain | - | 1.57e-09 | 39 | 25 | 5 | 2.120.10.30 | |
| Domain | Thbs/COMP_coiled-coil | 2.12e-09 | 3 | 25 | 3 | IPR024665 | |
| Domain | COMP | 2.12e-09 | 3 | 25 | 3 | PF11598 | |
| Domain | 6-blade_b-propeller_TolB-like | 3.71e-09 | 46 | 25 | 5 | IPR011042 | |
| Domain | TSPN | 2.17e-08 | 23 | 25 | 4 | SM00210 | |
| Domain | cEGF | 3.66e-08 | 26 | 25 | 4 | IPR026823 | |
| Domain | cEGF | 3.66e-08 | 26 | 25 | 4 | PF12662 | |
| Domain | - | 1.50e-07 | 95 | 25 | 5 | 2.60.120.200 | |
| Domain | ASX_HYDROXYL | 1.94e-07 | 100 | 25 | 5 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.60e-07 | 106 | 25 | 5 | IPR000152 | |
| Domain | Laminin_G | 1.01e-06 | 58 | 25 | 4 | IPR001791 | |
| Domain | DUF5050 | 1.72e-06 | 2 | 25 | 2 | IPR032485 | |
| Domain | DUF5050 | 1.72e-06 | 2 | 25 | 2 | PF16472 | |
| Domain | Relaxin_rcpt | 1.72e-06 | 2 | 25 | 2 | IPR008112 | |
| Domain | ConA-like_dom | 9.29e-06 | 219 | 25 | 5 | IPR013320 | |
| Domain | TSP_1 | 7.98e-05 | 63 | 25 | 3 | PF00090 | |
| Domain | TSP1 | 8.76e-05 | 65 | 25 | 3 | SM00209 | |
| Domain | TSP1_rpt | 8.76e-05 | 65 | 25 | 3 | IPR000884 | |
| Domain | TSP1 | 8.76e-05 | 65 | 25 | 3 | PS50092 | |
| Domain | VWC | 6.36e-04 | 28 | 25 | 2 | PF00093 | |
| Domain | VWFC_1 | 1.05e-03 | 36 | 25 | 2 | PS01208 | |
| Domain | VWC | 1.17e-03 | 38 | 25 | 2 | SM00214 | |
| Domain | VWFC_2 | 1.17e-03 | 38 | 25 | 2 | PS50184 | |
| Domain | VWF_dom | 1.43e-03 | 42 | 25 | 2 | IPR001007 | |
| Domain | EGF_extracell | 2.90e-03 | 60 | 25 | 2 | IPR013111 | |
| Domain | EGF_2 | 2.90e-03 | 60 | 25 | 2 | PF07974 | |
| Domain | LRRNT | 7.56e-03 | 98 | 25 | 2 | IPR000372 | |
| Domain | LRRNT | 7.56e-03 | 98 | 25 | 2 | SM00013 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.22e-07 | 84 | 25 | 5 | M7098 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 3.63e-07 | 86 | 25 | 5 | M2642 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.85e-06 | 57 | 25 | 4 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.06e-06 | 58 | 25 | 4 | M2049 | |
| Pathway | KEGG_FOCAL_ADHESION | 2.25e-05 | 199 | 25 | 5 | M7253 | |
| Pathway | WP_FOCAL_ADHESION | 2.25e-05 | 199 | 25 | 5 | M39402 | |
| Pathway | REACTOME_RELAXIN_RECEPTORS | 8.40e-05 | 8 | 25 | 2 | M27371 | |
| Pathway | REACTOME_RELAXIN_RECEPTORS | 1.35e-04 | 10 | 25 | 2 | MM15111 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 1.63e-04 | 302 | 25 | 5 | M39719 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3 | 2.33e-04 | 13 | 25 | 2 | M42551 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 2.33e-04 | 326 | 25 | 5 | MM15917 | |
| Pathway | WP_PI3KAKT_SIGNALING | 2.79e-04 | 339 | 25 | 5 | M39736 | |
| Pathway | WP_FOCAL_ADHESION | 3.05e-04 | 187 | 25 | 4 | MM15913 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 4.78e-04 | 381 | 25 | 5 | M48063 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 6.31e-04 | 96 | 25 | 3 | M39581 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 1.27e-03 | 30 | 25 | 2 | MM15812 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 1.27e-03 | 30 | 25 | 2 | M39641 | |
| Pathway | PID_INTEGRIN_A4B1_PATHWAY | 1.54e-03 | 33 | 25 | 2 | M277 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.15e-03 | 39 | 25 | 2 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.15e-03 | 39 | 25 | 2 | MM15165 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 2.46e-03 | 154 | 25 | 3 | MM15974 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 2.49e-03 | 42 | 25 | 2 | M174 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 2.56e-03 | 156 | 25 | 3 | M39475 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 2.61e-03 | 43 | 25 | 2 | M39565 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 2.85e-03 | 45 | 25 | 2 | MM15344 | |
| Pathway | REACTOME_SUMOYLATION | 3.21e-03 | 169 | 25 | 3 | MM14919 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 3.24e-03 | 48 | 25 | 2 | M27642 | |
| Pubmed | 1.55e-16 | 5 | 26 | 5 | 30622267 | ||
| Pubmed | Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear. | 8.68e-15 | 8 | 26 | 5 | 24460873 | |
| Pubmed | Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets. | 2.45e-13 | 4 | 26 | 4 | 6338048 | |
| Pubmed | 1.23e-12 | 5 | 26 | 4 | 18467703 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 3.13e-12 | 21 | 26 | 5 | 21337463 | |
| Pubmed | 8.07e-11 | 11 | 26 | 4 | 24639464 | ||
| Pubmed | 2.44e-10 | 14 | 26 | 4 | 15082773 | ||
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 9373030 | ||
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 18032585 | ||
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 25976449 | ||
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 34669362 | ||
| Pubmed | Thrombospondin 1 and thrombospondin 2 are expressed as both homo- and heterotrimers. | 3.71e-10 | 3 | 26 | 3 | 1459996 | |
| Pubmed | Pathological Significance and Prognostic Roles of Thrombospondin-3, 4 and 5 in Bladder Cancer. | 3.71e-10 | 3 | 26 | 3 | 33910854 | |
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 18178577 | ||
| Pubmed | Differential expression of thrombospondin 1, 2, and 3 during murine development. | 3.71e-10 | 3 | 26 | 3 | 8400410 | |
| Pubmed | Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction. | 3.71e-10 | 3 | 26 | 3 | 12482844 | |
| Pubmed | Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology. | 3.71e-10 | 3 | 26 | 3 | 26168731 | |
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 7775583 | ||
| Pubmed | 3.70e-09 | 5 | 26 | 3 | 19047013 | ||
| Pubmed | 3.70e-09 | 5 | 26 | 3 | 18685438 | ||
| Pubmed | 1.30e-08 | 7 | 26 | 3 | 12169628 | ||
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 1.34e-07 | 14 | 26 | 3 | 17389516 | |
| Pubmed | 3.00e-07 | 18 | 26 | 3 | 10827173 | ||
| Pubmed | 4.54e-07 | 210 | 26 | 5 | 16537572 | ||
| Pubmed | Induced thrombospondin expression in the mouse pancreas during pancreatic injury. | 5.37e-07 | 2 | 26 | 2 | 16181801 | |
| Pubmed | Expression of thrombospondin-1 in ischemia-induced retinal neovascularization. | 5.37e-07 | 2 | 26 | 2 | 10027393 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 17620335 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 26529358 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 5.37e-07 | 2 | 26 | 2 | 15963947 | |
| Pubmed | Corneal stromal cells (keratocytes) express thrombospondins 2 and 3 in wound repair phenotype. | 5.37e-07 | 2 | 26 | 2 | 11943589 | |
| Pubmed | The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2. | 5.37e-07 | 2 | 26 | 2 | 22973049 | |
| Pubmed | Human cytomegalovirus infection modulates thrombospondins 1 and 2 in primary fetal astrocytes. | 5.37e-07 | 2 | 26 | 2 | 23660684 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 34445520 | ||
| Pubmed | Associations of THBS2 and THBS4 polymorphisms to gastric cancer in a Southeast Chinese population. | 5.37e-07 | 2 | 26 | 2 | 27160021 | |
| Pubmed | Clearance of coagulation factor VIII in very low-density lipoprotein receptor knockout mice. | 5.37e-07 | 2 | 26 | 2 | 15327526 | |
| Pubmed | Thrombospondin 3 is a developmentally regulated heparin binding protein. | 5.37e-07 | 2 | 26 | 2 | 8288588 | |
| Pubmed | Expression and initial characterization of recombinant mouse thrombospondin 1 and thrombospondin 3. | 5.37e-07 | 2 | 26 | 2 | 8654563 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 39122122 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 34425286 | ||
| Pubmed | Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures. | 5.37e-07 | 2 | 26 | 2 | 22930728 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 11137453 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 24983516 | ||
| Pubmed | Modulation of thrombospondin expression during differentiation of embryonal carcinoma cells. | 5.37e-07 | 2 | 26 | 2 | 8126073 | |
| Pubmed | Relative abundance of thrombospondin 2 and thrombospondin 3 mRNAs in human tissues. | 5.37e-07 | 2 | 26 | 2 | 10329465 | |
| Pubmed | Polymorphisms A387P in thrombospondin-4 and N700S in thrombospondin-1 perturb calcium binding sites. | 5.37e-07 | 2 | 26 | 2 | 16148025 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 33981184 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 23875975 | ||
| Pubmed | Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. | 5.37e-07 | 2 | 26 | 2 | 18594557 | |
| Pubmed | Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis. | 5.37e-07 | 2 | 26 | 2 | 15037577 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 38339060 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 8350346 | ||
| Pubmed | COMP and TSP-4 interact specifically with the novel GXKGHR motif only found in fibrillar collagens. | 5.37e-07 | 2 | 26 | 2 | 30464261 | |
| Pubmed | Intermolecular interactions of thrombospondins drive their accumulation in extracellular matrix. | 5.37e-07 | 2 | 26 | 2 | 25995382 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 9045712 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 33372257 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 21762961 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 30928339 | ||
| Pubmed | Relaxin increases human endothelial progenitor cell NO and migration and vasculogenesis in mice. | 5.37e-07 | 2 | 26 | 2 | 22028476 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 17154366 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 9694593 | ||
| Pubmed | Resolving the unconventional mechanisms underlying RXFP1 and RXFP2 receptor function. | 5.37e-07 | 2 | 26 | 2 | 19416161 | |
| Pubmed | Modeling the primary hormone-binding site of RXFP1 and RXFP2. | 5.37e-07 | 2 | 26 | 2 | 19416162 | |
| Pubmed | Splice variants of the relaxin and INSL3 receptors reveal unanticipated molecular complexity. | 5.37e-07 | 2 | 26 | 2 | 16051677 | |
| Pubmed | Thrombospondin-4 contributes to spinal sensitization and neuropathic pain states. | 5.37e-07 | 2 | 26 | 2 | 22745497 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 14991768 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 12213711 | ||
| Pubmed | Increased cortical expression of two synaptogenic thrombospondins in human brain evolution. | 5.37e-07 | 2 | 26 | 2 | 17182969 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 17143334 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 29336258 | ||
| Pubmed | Biophysical characterization of the signature domains of thrombospondin-4 and thrombospondin-2. | 5.37e-07 | 2 | 26 | 2 | 16246837 | |
| Pubmed | Circulating Levels of Thrombospondin-1 and Thrombospondin-2 in Patients with Common Brain Tumors. | 5.37e-07 | 2 | 26 | 2 | 33759165 | |
| Pubmed | Thrombospondin expression in aldosterone-producing adenomas. | 5.37e-07 | 2 | 26 | 2 | 12358136 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 24877199 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 25393517 | ||
| Pubmed | A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome. | 5.37e-07 | 2 | 26 | 2 | 1712771 | |
| Pubmed | Conjunctival inflammation in thrombospondin-1 deficient mouse model of Sjögren's syndrome. | 5.37e-07 | 2 | 26 | 2 | 24086667 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 16963451 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 9.53e-07 | 101 | 26 | 4 | 23382219 | |
| Pubmed | A novel role for relaxin-2 in the pathogenesis of primary varicosis. | 1.61e-06 | 3 | 26 | 2 | 22737225 | |
| Pubmed | Reduced expression of thrombospondins and craniofacial dysmorphism in mice overexpressing Fra1. | 1.61e-06 | 3 | 26 | 2 | 16598380 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 26241338 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 27513329 | ||
| Pubmed | Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury. | 1.61e-06 | 3 | 26 | 2 | 18787106 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 15347840 | ||
| Pubmed | Extracellular matrix retention of thrombospondin 1 is controlled by its conserved C-terminal region. | 1.61e-06 | 3 | 26 | 2 | 18285447 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 11931574 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 18277139 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 15121769 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 23024363 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 20472562 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 31092423 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 19818485 | ||
| Pubmed | EWS/FLI1 regulates tumor angiogenesis in Ewing's sarcoma via suppression of thrombospondins. | 1.61e-06 | 3 | 26 | 2 | 17638877 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 30939949 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 11809971 | ||
| Pubmed | Thrombospondin 1 and Reelin act through Vldlr to regulate cardiac growth and repair. | 1.61e-06 | 3 | 26 | 2 | 38147128 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 34454945 | ||
| Pubmed | Interactions between CD47 and thrombospondin reduce inflammation. | 1.61e-06 | 3 | 26 | 2 | 17442977 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 16411781 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 19004835 | ||
| Interaction | ZFP41 interactions | 9.51e-09 | 57 | 26 | 5 | int:ZFP41 | |
| Interaction | ANKRD36B interactions | 1.24e-08 | 60 | 26 | 5 | int:ANKRD36B | |
| Interaction | THBS1 interactions | 5.43e-07 | 127 | 26 | 5 | int:THBS1 | |
| Interaction | THBS2 interactions | 1.82e-06 | 19 | 26 | 3 | int:THBS2 | |
| Interaction | ZNF224 interactions | 2.14e-06 | 20 | 26 | 3 | int:ZNF224 | |
| Interaction | THBS3 interactions | 2.35e-06 | 74 | 26 | 4 | int:THBS3 | |
| Interaction | IGFL3 interactions | 2.49e-06 | 75 | 26 | 4 | int:IGFL3 | |
| Interaction | LRPAP1 interactions | 3.04e-06 | 180 | 26 | 5 | int:LRPAP1 | |
| Interaction | NTN5 interactions | 3.79e-06 | 24 | 26 | 3 | int:NTN5 | |
| Interaction | DYRK1A interactions | 4.66e-06 | 552 | 26 | 7 | int:DYRK1A | |
| Interaction | FEZF1 interactions | 6.11e-06 | 28 | 26 | 3 | int:FEZF1 | |
| Interaction | LPL interactions | 1.21e-05 | 35 | 26 | 3 | int:LPL | |
| Interaction | CD36 interactions | 1.69e-05 | 39 | 26 | 3 | int:CD36 | |
| Interaction | ZNF408 interactions | 3.40e-05 | 145 | 26 | 4 | int:ZNF408 | |
| Interaction | THBS4 interactions | 4.46e-05 | 8 | 26 | 2 | int:THBS4 | |
| Interaction | SERPINE1 interactions | 4.53e-05 | 54 | 26 | 3 | int:SERPINE1 | |
| Interaction | TRO interactions | 9.44e-05 | 69 | 26 | 3 | int:TRO | |
| Interaction | ZNF563 interactions | 1.05e-04 | 12 | 26 | 2 | int:ZNF563 | |
| Interaction | APBB1 interactions | 1.08e-04 | 195 | 26 | 4 | int:APBB1 | |
| Interaction | CALCR interactions | 1.24e-04 | 13 | 26 | 2 | int:CALCR | |
| Interaction | RLN2 interactions | 1.44e-04 | 14 | 26 | 2 | int:RLN2 | |
| Interaction | SNX17 interactions | 1.52e-04 | 81 | 26 | 3 | int:SNX17 | |
| Interaction | CUBN interactions | 1.66e-04 | 15 | 26 | 2 | int:CUBN | |
| Interaction | LRP1B interactions | 1.76e-04 | 85 | 26 | 3 | int:LRP1B | |
| Interaction | MMP2 interactions | 1.88e-04 | 87 | 26 | 3 | int:MMP2 | |
| Interaction | DEFB123 interactions | 1.90e-04 | 16 | 26 | 2 | int:DEFB123 | |
| Interaction | SCN3A interactions | 1.90e-04 | 16 | 26 | 2 | int:SCN3A | |
| Interaction | CLU interactions | 2.58e-04 | 245 | 26 | 4 | int:CLU | |
| Interaction | SYT1 interactions | 3.27e-04 | 105 | 26 | 3 | int:SYT1 | |
| Interaction | EGFL6 interactions | 3.31e-04 | 21 | 26 | 2 | int:EGFL6 | |
| Interaction | DAB1 interactions | 3.46e-04 | 107 | 26 | 3 | int:DAB1 | |
| Interaction | MATN2 interactions | 4.06e-04 | 113 | 26 | 3 | int:MATN2 | |
| Interaction | CNPY4 interactions | 4.34e-04 | 24 | 26 | 2 | int:CNPY4 | |
| Interaction | SULF2 interactions | 4.73e-04 | 119 | 26 | 3 | int:SULF2 | |
| Interaction | ZDHHC15 interactions | 5.46e-04 | 125 | 26 | 3 | int:ZDHHC15 | |
| Interaction | GLI4 interactions | 5.46e-04 | 125 | 26 | 3 | int:GLI4 | |
| Interaction | TNFAIP6 interactions | 5.51e-04 | 27 | 26 | 2 | int:TNFAIP6 | |
| Interaction | PID1 interactions | 5.51e-04 | 27 | 26 | 2 | int:PID1 | |
| Interaction | ZNF517 interactions | 6.36e-04 | 29 | 26 | 2 | int:ZNF517 | |
| Interaction | MAP10 interactions | 6.36e-04 | 29 | 26 | 2 | int:MAP10 | |
| Interaction | LGALS1 interactions | 8.12e-04 | 332 | 26 | 4 | int:LGALS1 | |
| Interaction | ITGB1BP1 interactions | 8.25e-04 | 33 | 26 | 2 | int:ITGB1BP1 | |
| Interaction | ANKS1B interactions | 8.75e-04 | 34 | 26 | 2 | int:ANKS1B | |
| Interaction | BRD1 interactions | 9.27e-04 | 344 | 26 | 4 | int:BRD1 | |
| Interaction | SOST interactions | 9.28e-04 | 35 | 26 | 2 | int:SOST | |
| Cytoband | 1q25 | 9.94e-05 | 26 | 26 | 2 | 1q25 | |
| GeneFamily | Low density lipoprotein receptors | 1.60e-13 | 13 | 14 | 5 | 634 | |
| GeneFamily | Relaxin family peptide receptors | 3.34e-06 | 4 | 14 | 2 | 217 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.63e-02 | 394 | 14 | 2 | 471 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 9.20e-07 | 191 | 25 | 5 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.05e-06 | 196 | 25 | 5 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 5.02e-06 | 270 | 25 | 5 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 5.48e-06 | 275 | 25 | 5 | M5884 | |
| Coexpression | HALLMARK_COAGULATION | 8.54e-06 | 138 | 25 | 4 | M5946 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 2.41e-05 | 59 | 25 | 3 | M47993 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_UP | 3.60e-05 | 199 | 25 | 4 | M6638 | |
| Coexpression | GSE15767_MED_VS_SCS_MAC_LN_UP | 3.67e-05 | 200 | 25 | 4 | M3584 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 3.67e-05 | 200 | 25 | 4 | M5930 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 4.75e-05 | 74 | 25 | 3 | M13547 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C4 | 4.78e-05 | 11 | 25 | 2 | M566 | |
| Coexpression | LY_AGING_MIDDLE_UP | 7.89e-05 | 14 | 25 | 2 | M19146 | |
| Coexpression | OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN | 1.37e-04 | 281 | 25 | 4 | M7089 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | 1.83e-04 | 574 | 25 | 5 | M39056 | |
| Coexpression | AZARE_STAT3_TARGETS | 2.38e-04 | 24 | 25 | 2 | M2312 | |
| Coexpression | WILLIAMS_ESR1_TARGETS_UP | 2.80e-04 | 26 | 25 | 2 | M2970 | |
| Coexpression | NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS | 3.74e-04 | 30 | 25 | 2 | M47990 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_STROMAL_CELLS | 4.32e-04 | 156 | 25 | 3 | M40151 | |
| Coexpression | LIEN_BREAST_CARCINOMA_METAPLASTIC | 4.53e-04 | 33 | 25 | 2 | M11654 | |
| Coexpression | SIMBULAN_UV_RESPONSE_NORMAL_DN | 4.53e-04 | 33 | 25 | 2 | M16114 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 1.20e-04 | 408 | 26 | 5 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_100 | 1.56e-04 | 86 | 26 | 3 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.61e-04 | 87 | 26 | 3 | GSM777050_100 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.66e-04 | 437 | 26 | 5 | GSM777046_500 | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|(0)_Normal/No_Treatment / Stress and Cell class | 4.89e-08 | 173 | 26 | 5 | c2a0f674681836b5a868c13f67caa7d555ef6519 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-08 | 191 | 26 | 5 | 1b26056df078674f37a6c06f6256b30cfcec21a7 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.22e-08 | 192 | 26 | 5 | b35f0e422070ba9c7c1d9ff3eace4edc10286cde | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|World / Lineage and Cell class | 8.65e-08 | 194 | 26 | 5 | c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.87e-08 | 195 | 26 | 5 | d2c9c58b46bf96f9a536e177b995e340b55c6750 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-08 | 196 | 26 | 5 | 61bee32ca299219f31a30b57124e44e85b798e9f | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-08 | 196 | 26 | 5 | fcb275746bf51269ed8ba4cf93edb054a45f1ccd | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.34e-08 | 197 | 26 | 5 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-08 | 197 | 26 | 5 | cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40 | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|Mesenchymal_cells / Lineage and Cell class | 9.34e-08 | 197 | 26 | 5 | cb321836980e7b4efbb9284c6af7ccd34079d2be | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.58e-08 | 198 | 26 | 5 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.82e-08 | 199 | 26 | 5 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 1.55e-06 | 147 | 26 | 4 | 87c24843cb0e87ad42e725d08423131a5d2d25a3 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 3.02e-06 | 174 | 26 | 4 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class | 3.53e-06 | 181 | 26 | 4 | 56ae86072858c156681507aecd1bc6cb0a3372d2 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-06 | 184 | 26 | 4 | c9d7ec17cc5b7ba1b1e721ca392746e8f4a3d41f | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 3.77e-06 | 184 | 26 | 4 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | 3.77e-06 | 184 | 26 | 4 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-06 | 186 | 26 | 4 | a66da8453bb78f7e9f5f59452b3c50ae679d83c3 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.94e-06 | 186 | 26 | 4 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-06 | 190 | 26 | 4 | ad0f5605db6b694445ec9bd5dc8d2d834358c0f9 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-06 | 191 | 26 | 4 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-06 | 192 | 26 | 4 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-06 | 193 | 26 | 4 | 49600db68ed65cafc67bd45a285b364e4f5f88af | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-06 | 193 | 26 | 4 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | P15-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.65e-06 | 194 | 26 | 4 | 5f04d21c4e2d36e74b6c5889aa97fd98f75a0973 | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic-Chondrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.04e-06 | 198 | 26 | 4 | 55f013e9e6587d9ece59751fa131b1d22d6cceea | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.04e-06 | 198 | 26 | 4 | c72ef2ddcbb6dacbed4c6200d89e17d57314dcdc | |
| ToppCell | (1)_Osterolineage_cells-(11)_OLC-2|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 5.04e-06 | 198 | 26 | 4 | 9f9dcf23ffb333105263132d87b90095642294cf | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.14e-06 | 199 | 26 | 4 | 1fd7bbb8727607e6507848602a19bc86882ef2d5 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.14e-06 | 199 | 26 | 4 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | (2)_Fibroblasts|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 5.14e-06 | 199 | 26 | 4 | 777423b413376b0d3fbd92ff51dd0133fb54d293 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.14e-06 | 199 | 26 | 4 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.14e-06 | 199 | 26 | 4 | 9672230aa0bc6a7289050c955f5154ca183a5159 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.14e-06 | 199 | 26 | 4 | e18abe678da293bd01fae55e2f9ab6fdd643d02d | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.14e-06 | 199 | 26 | 4 | fb580e9321ddf97c73b2e356cd82523db74a38a2 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.25e-06 | 200 | 26 | 4 | 747c61d4e0b746278ae1f45ca4cd556c6961c76a | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-06 | 200 | 26 | 4 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-06 | 200 | 26 | 4 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.25e-06 | 200 | 26 | 4 | de1d193f773f4e2927baa6fc38d29754b015c6e6 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.59e-05 | 142 | 26 | 3 | a05b320cf182b2aaf18df7c40045dc65b659bf20 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.59e-05 | 142 | 26 | 3 | d52da766e031f7409eb5a7a9fa88f48e14a79d8b | |
| ToppCell | Ionocyte|World / shred by cell class for nasal brushing | 9.65e-05 | 154 | 26 | 3 | 6b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 160 | 26 | 3 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | (1)_Control_(PBS)-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 1.08e-04 | 160 | 26 | 3 | ab769516f9f7798d1390ef215caf22a2d3d53e63 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 160 | 26 | 3 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-04 | 166 | 26 | 3 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-04 | 166 | 26 | 3 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 168 | 26 | 3 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 169 | 26 | 3 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 169 | 26 | 3 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 169 | 26 | 3 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 171 | 26 | 3 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 171 | 26 | 3 | 007f148f4611ea1826edfa9f91ced36541ad9f5a | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 171 | 26 | 3 | 8e7223ba447947cdf4e1c82a52fd90439cf3d8f6 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Airway_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.36e-04 | 173 | 26 | 3 | b23b408acc29a667cce104429afef1a6cf2720a5 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 175 | 26 | 3 | 9d082ba0e350162aa6e71b668be074b12a27c7ab | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 175 | 26 | 3 | f641f34b52aec5d047430a6f9d026e915da6c11d | |
| ToppCell | facs-Skin-nan-24m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 175 | 26 | 3 | 21542be95059983d2c8bdf01ec711fdbf1ec1f62 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 176 | 26 | 3 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 176 | 26 | 3 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 176 | 26 | 3 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 176 | 26 | 3 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 176 | 26 | 3 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 176 | 26 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 176 | 26 | 3 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(1)_Control_(PBS) / Stress and Cell class | 1.46e-04 | 177 | 26 | 3 | d9e5ac5b8949a77e88e8094079167e4cf2c1bbd1 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.48e-04 | 178 | 26 | 3 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.48e-04 | 178 | 26 | 3 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Macrophage|lymph-node_spleen / Manually curated celltypes from each tissue | 1.51e-04 | 179 | 26 | 3 | b4430f633711cecf793e8e76e766a66ff1eff473 | |
| ToppCell | facs-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 180 | 26 | 3 | 72310baeed848f2c483ae986cd73d2fb2cca7feb | |
| ToppCell | droplet-Limb_Muscle-nan-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 180 | 26 | 3 | d3d0be136fff5d3e39ecf5a5dbefc1d0d0a6c814 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-04 | 181 | 26 | 3 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 181 | 26 | 3 | e1ae9ada60ec89e7a7cde9c231c1a099ed2ffecc | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.56e-04 | 181 | 26 | 3 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.58e-04 | 182 | 26 | 3 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 182 | 26 | 3 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.58e-04 | 182 | 26 | 3 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 182 | 26 | 3 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 182 | 26 | 3 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.61e-04 | 183 | 26 | 3 | 06e4b05d86a7d643569e19575c2c9aa351d33f29 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 184 | 26 | 3 | 8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 184 | 26 | 3 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 184 | 26 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 185 | 26 | 3 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 1.66e-04 | 185 | 26 | 3 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 186 | 26 | 3 | cd6502bbf9dce318fdbb4965d49df8951e5f795c | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 186 | 26 | 3 | b58db5abdd3e9f0214b198c3cbd09b0b3c321eab | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-04 | 186 | 26 | 3 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.69e-04 | 186 | 26 | 3 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-04 | 187 | 26 | 3 | fa8f221b4c2df61eadaa9c77e4cf45848b00330b | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|Mesenchymal_cells / Lineage and Cell class | 1.71e-04 | 187 | 26 | 3 | e899b906409f3fad69cb3d3c6432c3fd862ae3c1 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.71e-04 | 187 | 26 | 3 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.74e-04 | 188 | 26 | 3 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.74e-04 | 188 | 26 | 3 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 188 | 26 | 3 | 8cc927b4c51d982fdafa04dc7393617ad9bb220e | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | 56f43e00d81cf3cdf0c39f8d7120f5beab72e258 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | 544d95df910f1b276995624509a7e41b219baca0 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.77e-04 | 189 | 26 | 3 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.77e-04 | 189 | 26 | 3 | 40cbd679dc0548bf5207e1b033c0597886ad6fe1 | |
| Computational | Metal / Ca ion binding. | 1.38e-04 | 133 | 22 | 4 | MODULE_324 | |
| Drug | monatepil | 2.64e-08 | 29 | 25 | 4 | CID000060810 | |
| Drug | Chr 5 | 2.24e-07 | 125 | 25 | 5 | CID006448119 | |
| Drug | ezetimibe | 5.02e-07 | 147 | 25 | 5 | CID000150311 | |
| Drug | probucol | 8.12e-07 | 162 | 25 | 5 | CID000004912 | |
| Drug | Epi Lovastatin | 1.50e-06 | 341 | 25 | 6 | CID000003962 | |
| Drug | AC1OAGKW | 1.92e-06 | 193 | 25 | 5 | CID006857413 | |
| Drug | sodium cholate | 4.24e-06 | 408 | 25 | 6 | CID000000303 | |
| Drug | LMWH | 5.23e-06 | 663 | 25 | 7 | CID000000772 | |
| Drug | vitamin E | 6.61e-06 | 441 | 25 | 6 | CID000002116 | |
| Drug | pitavastatin | 6.95e-06 | 114 | 25 | 4 | CID005282451 | |
| Drug | HepII | 1.40e-05 | 43 | 25 | 3 | CID003036269 | |
| Drug | pristane | 2.17e-05 | 152 | 25 | 4 | CID000015979 | |
| Drug | Nor 3 | 2.22e-05 | 50 | 25 | 3 | CID009578441 | |
| Drug | 25-hydroxycholesterol | 2.65e-05 | 160 | 25 | 4 | CID000065094 | |
| Drug | Furosemide | 2.92e-05 | 164 | 25 | 4 | ctd:D005665 | |
| Drug | 5224221; Up 200; 12uM; MCF7; HT_HG-U133A_EA | 4.11e-05 | 179 | 25 | 4 | 839_UP | |
| Drug | coprogen | 4.15e-05 | 9 | 25 | 2 | CID006323272 | |
| Drug | Amoxicillin [26787-78-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 4.67e-05 | 185 | 25 | 4 | 2620_DN | |
| Drug | 17alpha-estradiol | 5.07e-05 | 1303 | 25 | 8 | CID000000450 | |
| Drug | 25-azacoprostane | 5.18e-05 | 10 | 25 | 2 | CID000162243 | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 5.40e-05 | 192 | 25 | 4 | 4104_DN | |
| Drug | simvastatin | 5.76e-05 | 390 | 25 | 5 | CID000054454 | |
| Drug | Aminohippuric acid [61-78-9]; Down 200; 20.6uM; MCF7; HT_HG-U133A | 5.85e-05 | 196 | 25 | 4 | 5394_DN | |
| Drug | Flurandrenolide [1524-88-5]; Up 200; 9.2uM; PC3; HT_HG-U133A | 5.85e-05 | 196 | 25 | 4 | 7378_UP | |
| Drug | Etofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 5.85e-05 | 196 | 25 | 4 | 4108_DN | |
| Drug | Propidium iodide [25535-16-4]; Up 200; 6uM; MCF7; HT_HG-U133A | 5.96e-05 | 197 | 25 | 4 | 6277_UP | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; PC3; HT_HG-U133A | 5.96e-05 | 197 | 25 | 4 | 6664_UP | |
| Drug | Flunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 6.08e-05 | 198 | 25 | 4 | 7013_UP | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 6.20e-05 | 199 | 25 | 4 | 5494_DN | |
| Drug | chondroitin sulfate | 7.55e-05 | 413 | 25 | 5 | CID000024766 | |
| Drug | diethyl malate | 1.13e-04 | 86 | 25 | 3 | ctd:C058705 | |
| Drug | AC1L1J6H | 1.20e-04 | 236 | 25 | 4 | CID000004889 | |
| Drug | Rgd Peptide | 1.26e-04 | 239 | 25 | 4 | CID000104802 | |
| Drug | imidazoquinoline | 1.82e-04 | 101 | 25 | 3 | CID005351568 | |
| Drug | HepI | 2.17e-04 | 20 | 25 | 2 | CID003036968 | |
| Drug | Calpain inhibitor I | 2.31e-04 | 280 | 25 | 4 | CID000004332 | |
| Drug | troglitazone | 2.34e-04 | 526 | 25 | 5 | CID000005591 | |
| Drug | tetraphenylporphyrin | 2.40e-04 | 21 | 25 | 2 | CID000070186 | |
| Drug | dihydroacarbose | 2.53e-04 | 113 | 25 | 3 | CID000174450 | |
| Drug | fs x | 2.89e-04 | 23 | 25 | 2 | CID000444420 | |
| Drug | arginine butyrate | 3.42e-04 | 25 | 25 | 2 | CID000054566 | |
| Drug | dansylamide | 3.56e-04 | 127 | 25 | 3 | CID000065077 | |
| Drug | isocycloheximide | 3.59e-04 | 905 | 25 | 6 | CID000002900 | |
| Drug | tetrahydroaldosterone-3-glucuronide | 4.61e-04 | 29 | 25 | 2 | CID000167918 | |
| Drug | 5br20686 | 4.61e-04 | 29 | 25 | 2 | CID000447088 | |
| Drug | trypanothione disulfide | 4.74e-04 | 140 | 25 | 3 | CID000115098 | |
| Drug | sodium linoleate | 4.93e-04 | 342 | 25 | 4 | CID000003931 | |
| Drug | Ne 2 | 4.94e-04 | 30 | 25 | 2 | CID000119346 | |
| Drug | 2-methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide | 5.28e-04 | 31 | 25 | 2 | ctd:C577942 | |
| Drug | raloxifene | 5.44e-04 | 351 | 25 | 4 | CID000005035 | |
| Drug | emtricitabine | 5.46e-04 | 147 | 25 | 3 | CID000060877 | |
| Drug | epicholesterol | 5.59e-04 | 636 | 25 | 5 | CID000000304 | |
| Drug | AC1NX069 | 5.63e-04 | 32 | 25 | 2 | CID005716906 | |
| Drug | butyl benzyl phthalate | 5.63e-04 | 32 | 25 | 2 | CID000002347 | |
| Drug | ABT510 | 5.63e-04 | 32 | 25 | 2 | CID006918562 | |
| Drug | uPA inhibitor | 5.63e-04 | 32 | 25 | 2 | CID000001746 | |
| Drug | biphenylene | 6.36e-04 | 34 | 25 | 2 | CID000009214 | |
| Drug | geldanamycin | 6.69e-04 | 371 | 25 | 4 | ctd:C001277 | |
| Drug | 15d-PGJ2; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 6.87e-04 | 159 | 25 | 3 | 1011_UP | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 7.25e-04 | 162 | 25 | 3 | 1655_UP | |
| Drug | o-Phthalaldehyde | 7.94e-04 | 38 | 25 | 2 | ctd:D009764 | |
| Drug | thapsigargin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 8.05e-04 | 168 | 25 | 3 | 7100_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 8.34e-04 | 170 | 25 | 3 | 1631_UP | |
| Drug | thapsigargin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 8.34e-04 | 170 | 25 | 3 | 7053_UP | |
| Drug | Val-Val | 8.37e-04 | 39 | 25 | 2 | CID000107475 | |
| Drug | Al per | 8.37e-04 | 39 | 25 | 2 | CID009576740 | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 8.92e-04 | 174 | 25 | 3 | 972_UP | |
| Drug | 2,6-dihydroxybenzoic acid | 9.06e-04 | 175 | 25 | 3 | CID000009338 | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A | 9.06e-04 | 175 | 25 | 3 | 1653_UP | |
| Drug | AC1NAL8H | 9.25e-04 | 41 | 25 | 2 | CID004478772 | |
| Drug | pararosaniline base; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 9.37e-04 | 177 | 25 | 3 | 893_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 9.52e-04 | 178 | 25 | 3 | 916_UP | |
| Drug | Disulfiram [97-77-8]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 9.68e-04 | 179 | 25 | 3 | 6210_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 9.68e-04 | 179 | 25 | 3 | 1005_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 9.83e-04 | 180 | 25 | 3 | 947_UP | |
| Drug | 17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A | 9.99e-04 | 181 | 25 | 3 | 5573_UP | |
| Drug | Fenoterol hydrobromide [1944-12-3]; Up 200; 10.4uM; PC3; HT_HG-U133A | 1.02e-03 | 182 | 25 | 3 | 6331_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.02e-03 | 182 | 25 | 3 | 998_UP | |
| Drug | Murabutida | 1.02e-03 | 43 | 25 | 2 | CID005362018 | |
| Drug | darifenicin | 1.02e-03 | 43 | 25 | 2 | CID000072054 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 1.03e-03 | 183 | 25 | 3 | 6944_UP | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 1.03e-03 | 183 | 25 | 3 | 2696_DN | |
| Drug | valinomycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.05e-03 | 184 | 25 | 3 | 5957_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.06e-03 | 185 | 25 | 3 | 831_UP | |
| Drug | Naftifine hydrochloride [65473-14-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.06e-03 | 185 | 25 | 3 | 3536_UP | |
| Drug | Alclometasone dipropionate [667634-13-2]; Up 200; 7.6uM; HL60; HT_HG-U133A | 1.06e-03 | 185 | 25 | 3 | 2532_UP | |
| Drug | NC-4 | 1.06e-03 | 44 | 25 | 2 | CID006420119 | |
| Drug | lasofoxifene | 1.06e-03 | 44 | 25 | 2 | CID000216416 | |
| Drug | methoxyl | 1.06e-03 | 44 | 25 | 2 | CID000123146 | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.10e-03 | 187 | 25 | 3 | 4323_DN | |
| Drug | Mometasone furoate [83919-23-7]; Up 200; 7.6uM; PC3; HT_HG-U133A | 1.10e-03 | 187 | 25 | 3 | 5116_UP | |
| Disease | Microangiopathy, Diabetic | 7.56e-05 | 16 | 24 | 2 | C0025945 | |
| Disease | Diabetic Angiopathies | 7.56e-05 | 16 | 24 | 2 | C0011875 | |
| Disease | epilepsy (implicated_via_orthology) | 3.08e-04 | 163 | 24 | 3 | DOID:1826 (implicated_via_orthology) | |
| Disease | pack-years measurement, systolic blood pressure | 3.50e-04 | 34 | 24 | 2 | EFO_0006335, EFO_0006526 | |
| Disease | urate measurement | 6.68e-04 | 895 | 24 | 5 | EFO_0004531 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NGDQDCLDGSDEDDC | 116 | P07357 | |
| VGDACDSDQDQDGDG | 426 | P49747 | |
| CEEENAGAEDQDGEG | 496 | Q5ZPR3 | |
| DGDNDCGDFSDEAQI | 1026 | Q9NZR2 | |
| CDGENDCGDNSDELD | 2571 | Q9NZR2 | |
| CDGENDCGDNSDELN | 3376 | Q9NZR2 | |
| WGDEADGGQQEDDSG | 21 | Q8IXH7 | |
| DGGQQEDDSGEGEDD | 26 | Q8IXH7 | |
| GDLLCDDDNEDQGDN | 251 | B7ZW38 | |
| CDNDNDCGDNSDEAG | 996 | Q07954 | |
| CDGNDDCGDGSDEGE | 1166 | Q07954 | |
| NAMDADGGDDDDQGS | 321 | Q86VP6 | |
| GDLLCDDDNEDQGDN | 251 | P0DMR1 | |
| CDGEDDCKDNGDEDG | 241 | P98164 | |
| LCDGDNDCGDNSDEN | 2841 | P98164 | |
| GQEDGGDDKENHGEC | 511 | Q8WY54 | |
| GQADCDDDSDEENCG | 601 | Q9Y5Q5 | |
| KDDDGGEDDDANCNL | 596 | Q08211 | |
| RAEDEECENDGVGGN | 301 | P78356 | |
| DGKDDCGNGADEENC | 66 | Q8WXD0 | |
| EDNGLEENSGDGQED | 101 | Q15424 | |
| ACDEDADGDGILNEQ | 506 | P35443 | |
| KDGIGDACDDDDDND | 731 | P07996 | |
| ADTDNNGEGDACAAD | 786 | P07996 | |
| NGEGDACAADIDGDG | 791 | P07996 | |
| DEDNDGNEGDNEGSD | 571 | Q9H2G4 | |
| GNEGDNEGSDDDGNE | 576 | Q9H2G4 | |
| NEGSDDDGNEGDNEG | 581 | Q9H2G4 | |
| DDGNEGDNEGSDDDD | 586 | Q9H2G4 | |
| NNEGDGDEEGENEEE | 466 | O00541 | |
| DGNDGYEADDAEGGD | 1996 | P12270 | |
| DDCGNQADEDNCGDN | 51 | Q9HBX9 | |
| QEDADNDGVGDQCDD | 491 | P49746 | |
| NDGVGDQCDDDADGD | 496 | P49746 | |
| KDTDGNGEGDACDND | 551 | P49746 | |
| NGEGDACDNDVDGDG | 556 | P49746 | |
| DNDGLGDECDGDDDN | 651 | P49746 | |
| GDECDGDDDNDGIPD | 656 | P49746 | |
| DGNGVGDVCEDDFDN | 691 | P49746 | |
| GQGDACDPDDDNDGV | 891 | P35442 | |
| GENDCDSGEDEENCG | 136 | P98155 | |
| GDNDCGDNSDEQCDM | 131 | O75096 |